Exo Debuts New Point-of-Care Ultrasound Modality
The Exo Iris reportedly combines advanced silicon technology with imaging, workflow software and artificial intelligence (AI) to facilitate multidisciplinary use of point-of-care ultrasound.
Emphasizing ease of use, enhanced imaging quality and artificial intelligence features, Exo has launched the Exo Iris point-of-care ultrasound modality.
In addition to acquiring images with a sweep of one’s wrist via patented SweepAI™ technology, the
The company said other features of Exo Iris include the ability of the ultrasound platform to provide multi-organ scans, assess fine structures and offer guidance for IVs and line procedures.
Key AI features include assessment of bladder volume in seconds with Bladder AI and forthcoming real-time guidance and triage capabilities with Cardiac and Lung AI suites that are pending FDA 510(k) clearance, according to Exo.
“Exo Iris delivers an entirely new approach to the design of ultrasound; one that doesn’t look at ultrasound as a device-only purchase, but seamlessly brings together a complete solution that includes imaging, workflow, and real-time AI in one platform,” noted Arun Nagdev, M.D., the senior director of clinical education at Exo.
Related to this article
